DongKook Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 3,547 million compared to KRW 5,825.44 million a year ago. Net income was KRW 16,033.29 million compared to KRW 15,699.23 million a year ago.

Basic earnings per share from continuing operations was KRW 365 compared to KRW 357 a year ago. Diluted earnings per share from continuing operations was KRW 358 compared to KRW 351 a year ago. Basic earnings per share was KRW 365 compared to KRW 357 a year ago.

Diluted earnings per share was KRW 358 compared to KRW 351 a year ago.